BeOne Medicines (ONC) Revenue Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.82% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 19.04% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3,790.58% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 35.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.46% |
| Dec 31, 2025 | 32.84% |
| Sep 30, 2025 | 41.00% |
| Jun 30, 2025 | 41.56% |
| Mar 31, 2025 | 48.64% |
| Dec 31, 2024 | 77.78% |
| Sep 30, 2024 | 28.20% |
| Jun 30, 2024 | 56.09% |
| Mar 31, 2024 | 67.85% |
| Dec 31, 2023 | 66.91% |
| Sep 30, 2023 | 101.56% |
| Jun 30, 2023 | 74.27% |
| Mar 31, 2023 | 46.04% |
| Dec 31, 2022 | 77.63% |
| Sep 30, 2022 | 87.77% |
| Jun 30, 2022 | 127.73% |
| Mar 31, 2022 | -49.39% |
| Dec 31, 2021 | 113.77% |
| Sep 30, 2021 | 126.66% |
| Jun 30, 2021 | 128.52% |
| Mar 31, 2021 | 1,063.82% |
| Dec 31, 2020 | 75.95% |
| Sep 30, 2020 | 81.65% |
| Jun 30, 2020 | -56.24% |
| Mar 31, 2020 | -33.11% |
| Dec 31, 2019 | -3.03% |
| Sep 30, 2019 | -7.49% |
| Jun 30, 2019 | 184.07% |
| Mar 31, 2019 | 139.16% |
| Dec 31, 2018 | 222.82% |
| Sep 30, 2018 | -75.39% |
| Jun 30, 2016 | -71.52% |
| Mar 31, 2016 | -50.91% |